Cite
Investigation and management of the monoclonal gammopathy of undetermined significance: A British Society for Haematology Good Practice Paper.
MLA
Stern, Simon, et al. “Investigation and Management of the Monoclonal Gammopathy of Undetermined Significance: A British Society for Haematology Good Practice Paper.” British Journal of Haematology, vol. 202, no. 4, Aug. 2023, pp. 734–44. EBSCOhost, https://doi.org/10.1111/bjh.18866.
APA
Stern, S., Chaudhuri, S., Drayson, M., Henshaw, S., Karunanithi, K., & Willis, F. (2023). Investigation and management of the monoclonal gammopathy of undetermined significance: A British Society for Haematology Good Practice Paper. British Journal of Haematology, 202(4), 734–744. https://doi.org/10.1111/bjh.18866
Chicago
Stern, Simon, Satarupa Chaudhuri, Mark Drayson, Sarah Henshaw, Kamaraj Karunanithi, and Fenella Willis. 2023. “Investigation and Management of the Monoclonal Gammopathy of Undetermined Significance: A British Society for Haematology Good Practice Paper.” British Journal of Haematology 202 (4): 734–44. doi:10.1111/bjh.18866.